The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.

The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.